BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20160101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171206
DTEND;VALUE=DATE:20171208
DTSTAMP:20260515T113624
CREATED:20170922T053049Z
LAST-MODIFIED:20170925T092546Z
UID:3194-1512518400-1512691199@www.pharmajournalist.com
SUMMARY:2nd Outsourcing in clinical trials (OCT) East Asia
DESCRIPTION:The aim of the event is to offer case studies and insight into how to effectively outsource and manager clinical trials throughout East Asia. The programme incorporates insight from both small and big pharma and sessions will take place in both English and Korean. \nThis year’s event is taking place in Seoul\, (South Korea) where there is a good balance of local and global pharma companies. Korea has made huge steps towards being recognised as a key player in pharma by specialising in biosimilar \nWhy South Korea? \nThe event is taking place in South Korea\, this is because there is a good balance of local and global pharma companies. Korea also has made huge steps towards being recognised as a key player in pharma by specialising in biosimilar. \nTo learn more about this event\, and to register online\, visit https://goo.gl/cGi5Qy
URL:https://www.pharmajournalist.com/event/2nd-outsourcing-clinical-trials-oct-east-asia/
LOCATION:Seoul\, South Korea
ORGANIZER;CN="Arena International":MAILTO:brijesh.patel@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171206
DTEND;VALUE=DATE:20171208
DTSTAMP:20260515T113624
CREATED:20170925T092900Z
LAST-MODIFIED:20170925T092900Z
UID:3237-1512518400-1512691199@www.pharmajournalist.com
SUMMARY:3rd Annual Clinical Trial Supply (CTS) East Asia
DESCRIPTION:This event has now reached its third birthday and is fast becoming an industry must attend show. Since 2015 the event is forecast to almost double in revenue and it’s imperative that the program brings together a mixture of the biggest companies to keep attracting vendors. \nThe delegate campaign has been very successful in both 2015 and 2016\, attracting a large number of attendees from South Korea\, Japan\, China\, Taiwan and Singapore. It’s important that this mix is reflected on the program and that presentations are sought from across East Asia. \n Why CTS East Asia? \nAsia now has more clinical trials than any other region in the world. Through research with suppliers there is some disagreement over whether the local market is growing in terms of companies\, however no dispute at all in the number of trials happening in the region. \nTo learn more about this event\, and to register online\, visit https://goo.gl/UdMMN7
URL:https://www.pharmajournalist.com/event/3rd-annual-clinical-trial-supply-cts-east-asia/
LOCATION:Seoul\, South Korea
ORGANIZER;CN="Arena International":MAILTO:brijesh.patel@arena-international.com
END:VEVENT
END:VCALENDAR